Vitamin D and Omega-3 Fatty Acids (VITAL Trial): Effects on Fractures [ANCILLARY OF 700049031]

Trial Profile

Vitamin D and Omega-3 Fatty Acids (VITAL Trial): Effects on Fractures [ANCILLARY OF 700049031]

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Mar 2017

At a glance

  • Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
  • Indications Fracture
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Mar 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2017.
    • 14 Mar 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.
    • 17 Apr 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Jun 2016 to 1 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top